Procter & Gamble Company (The) (NYSE:PG) Given Consensus Rating of “Moderate Buy” by Analysts

Procter & Gamble Company (The) (NYSE:PG) has been assigned an average recommendation of “Moderate Buy” from the twenty-one ratings firms that are presently covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $167.0556.

PG has been the subject of several analyst reports. UBS Group boosted their price target on shares of Procter & Gamble from $161.00 to $170.00 and gave the company a “buy” rating in a report on Friday, January 23rd. BNP Paribas Exane dropped their price objective on shares of Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating on the stock in a report on Friday, January 16th. Dbs Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Friday, January 23rd. Barclays set a $155.00 target price on shares of Procter & Gamble in a research report on Friday, January 16th. Finally, JPMorgan Chase & Co. upgraded shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and raised their price target for the company from $157.00 to $165.00 in a research note on Friday, January 23rd.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Investors are rotating into defensive, dividend-rich consumer staples as recession odds rise, which supports demand for PG stock as a low-beta hedge. As Recession Odds Climb, Defensive Sectors Continue to Outperform (PG)
• Positive Sentiment: New OLAY peptide research was presented at a dermatology conference and P&G plans to integrate proprietary peptide technologies into product formulas—an R&D catalyst that could support premium pricing and brand value over time. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
• Positive Sentiment: Recent session saw PG outperform the market on a prior close, reflecting investor preference for staples amid broader weakness. This shows defensive demand can provide near-term support. Procter & Gamble (PG) Ascends While Market Falls
• Neutral Sentiment: Analysts expect P&G’s upcoming fiscal Q3 results to show low single-digit EPS growth—this raises the bar modestly: a beat could lift the stock, while a slight miss may reinforce current caution. What to Expect From Procter & Gamble’s Next Quarterly Earnings Report
• Neutral Sentiment: Market commentary and analyst notes on consumer goods (including P&G and peers) are circulating, offering mixed takes that could influence near-term analyst revisions but contain no single decisive catalyst. Analysts Offer Insights on Consumer Goods Companies: Procter & Gamble (PG) and Costco (COST)
• Negative Sentiment: TD Cowen cut its price target to $142 from $156 and kept a Hold rating, citing oil-related input-cost inflation tied to geopolitical tensions—this analyst action puts downward pressure on sentiment and could limit near-term upside. TD Cowen Adjusts Price Target on Procter & Gamble to $142 from $156; Maintains Hold Rating
• Negative Sentiment: Reports say Deutsche Bank has lowered expectations for P&G, and coverage notes broadly point to cost pressures (including oil-related input inflation from Middle East tensions) that could compress margins if raw-material costs accelerate. Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Procter & Gamble (NYSE:PG) Stock Price
• Negative Sentiment: Coverage summarizing analyst downgrades highlights Iran-war related cost risks and has contributed to recent negative headlines and downgrades that weigh on sentiment. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More

Procter & Gamble Stock Down 0.2%

Shares of Procter & Gamble stock opened at $144.19 on Friday. The stock has a market capitalization of $335.10 billion, a price-to-earnings ratio of 21.36, a PEG ratio of 5.08 and a beta of 0.41. Procter & Gamble has a twelve month low of $137.62 and a twelve month high of $174.80. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.49. The business’s 50 day simple moving average is $153.85 and its 200-day simple moving average is $149.84.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, January 23rd. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The firm had revenue of $22.21 billion during the quarter, compared to the consensus estimate of $22.36 billion. During the same period in the prior year, the business earned $1.88 EPS. The firm’s revenue was up 1.5% on a year-over-year basis. Equities research analysts forecast that Procter & Gamble will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were given a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.9%. The ex-dividend date was Friday, January 23rd. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.67%.

Insider Activity

In related news, Chairman Jon R. Moeller sold 162,232 shares of Procter & Gamble stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the sale, the chairman directly owned 319,385 shares in the company, valued at $51,884,093.25. The trade was a 33.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the company’s stock in a transaction dated Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the sale, the insider directly owned 44,735 shares of the company’s stock, valued at $7,259,595.80. The trade was a 25.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 348,618 shares of company stock worth $55,462,643 over the last ninety days. 0.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Procter & Gamble

Large investors have recently bought and sold shares of the stock. Halbert Hargrove Global Advisors LLC acquired a new position in shares of Procter & Gamble during the third quarter valued at approximately $25,000. E Fund Management Hong Kong Co. Ltd. lifted its position in Procter & Gamble by 1,000.0% in the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the period. Park Square Financial Group LLC boosted its stake in Procter & Gamble by 65.1% during the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock valued at $26,000 after purchasing an additional 71 shares in the last quarter. Evolution Wealth Management Inc. boosted its stake in Procter & Gamble by 1,315.4% during the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after purchasing an additional 171 shares in the last quarter. Finally, Litman Gregory Wealth Management LLC acquired a new position in shares of Procter & Gamble during the 4th quarter valued at $26,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.